viral
metagenom
recent
yield
numer
previous
uncharacter
viral
genom
human
anim
sampl
review
metagenom
tool
strategi
determin
orphan
virus
like
pathogen
diseas
associ
studi
compar
viral
preval
patient
unexplain
symptom
versu
healthi
individu
requir
case
control
group
close
match
epidemiolog
develop
antibodi
respons
convalesc
serum
temporarili
link
symptom
recent
infect
neutral
antibodi
detect
requir
often
difficult
cell
cultur
viru
amplif
antibodi
bind
assay
requir
proper
antigen
synthesi
posit
control
sera
set
assay
threshold
high
level
viral
genet
divers
within
orphan
viral
group
frequent
coinfect
low
rare
pathogen
chronic
viru
shed
complic
diseas
associ
studi
limit
avail
match
case
control
sampl
set
differ
age
group
geograph
origin
major
block
estim
pathogen
potenti
recent
character
orphan
virus
current
limit
practic
use
deep
sequenc
viral
diagnost
list
viral
metagenom
directli
character
genet
materi
viral
commun
bypass
need
prior
virusspecif
vitro
vivo
amplif
viral
metagenom
initi
use
analyz
environment
sampl
use
sanger
shotgun
sequenc
rapidli
expand
includ
sampl
human
anim
fece
blood
tissu
respiratori
secret
often
use
next
gener
sequenc
viral
metagenom
deep
sequenc
larg
focus
viral
discoveri
identifi
new
pathogen
sequenc
viral
variant
known
speci
better
understand
evolut
unbias
survey
viral
commun
without
diversityreduc
effect
prior
amplif
cell
cultur
viral
metagenom
also
use
detect
low
titer
viru
character
full
viral
genom
circumv
need
molecular
method
requir
stringent
nucleotid
hybrid
pcr
microarray
due
earlier
introduct
longer
read
length
facilit
recognit
highli
diverg
viral
sequenc
roch
system
popular
highthroughput
sequenc
tool
viral
discoveri
less
expens
per
base
pair
shorter
sequenc
read
illumina
genom
analyz
platform
gradual
increas
popular
sequenc
technolog
deliv
data
hour
instead
day
includ
ion
torrent
pacif
bioscienc
recent
introduc
yield
fewer
read
high
rate
sequenc
error
inher
mani
high
throughput
technolog
frameshift
insertiondelet
indel
mutat
disrupt
viral
open
read
frame
thu
interfer
protein
similar
search
impact
identif
highli
diverg
virus
indel
less
impact
identif
alreadi
known
viral
pathogen
possibl
use
nucleotid
similar
search
sequenc
high
titer
virus
sequenc
error
correct
assembl
consensu
sequenc
genom
numer
overlap
sequenc
cover
nucleotid
posit
deep
sequenc
may
also
use
detect
rare
variant
hiv
drug
resist
mutant
present
minor
within
larg
wildtyp
viral
quasispeci
directli
sequenc
nucleic
acid
biolog
fluid
without
prior
viral
particl
enrich
result
high
background
host
bacteri
genet
materi
includ
chromosom
episom
ribosom
sequenc
reduc
background
virus
purifi
use
simpl
filtrat
method
exclud
larger
particl
nucleas
treatment
also
use
digest
nake
cellular
nucleic
acid
abund
biolog
fluid
viral
nucleic
acid
remain
protect
within
viral
capsid
larg
sampl
volum
avail
environment
studi
ultracentrifug
method
also
use
concentr
purifi
viral
particl
expect
densiti
band
regardless
sequenc
technolog
use
viral
nucleic
acid
amplifi
gener
larg
quantiti
dna
requir
sequenc
platform
sinc
mani
virus
rna
genom
detect
first
requir
genom
rna
revers
transcrib
cdna
numer
sequenceindepend
amplif
method
success
use
two
basic
approach
predomin
random
pcr
base
degener
end
pcr
primer
use
randomli
prime
dna
synthesi
degeneraci
allow
primer
anneal
throughout
length
viral
rna
dna
genom
follow
two
round
extens
place
primer
extrem
viral
sequenc
multipl
round
pcr
amplif
perform
primer
lack
degener
end
nnnnnn
method
analog
one
commonli
use
gener
fluoresc
label
cdna
analysi
transcriptom
microarray
relat
techniqu
call
sequenceindepend
singl
primer
amplif
sispa
involv
partial
cleavag
doubl
strand
cdna
gener
short
random
primer
use
recogn
restrict
enzym
follow
ligat
sticki
adaptor
pcr
use
primer
complementari
adaptor
anoth
popular
random
amplif
method
involv
use
highli
process
dna
polymeras
short
random
primer
multipl
displac
amplif
possibl
bia
amplif
circular
dna
viral
genom
may
occur
use
viral
rna
also
amplifi
revers
transcript
ligat
cdna
molecul
long
chimer
dna
molecul
appropri
dna
polymeras
amplif
facilit
recognit
novel
virus
overlap
sequenc
read
first
comput
assembl
longer
contig
less
complex
nucleic
acid
popul
greater
number
read
collaps
contig
contig
unassembl
singleton
subject
search
public
sequenc
databas
use
blast
suit
tool
nucleotid
similar
quickli
identifi
sequenc
close
relat
known
viral
speci
previous
uncharacter
viral
speci
highli
diverg
alreadi
public
databas
may
unrecogniz
use
nucleotid
similar
search
requir
comput
demand
comparison
virtual
translat
product
known
viral
protein
order
detect
weaker
match
limit
similaritybas
approach
still
uncharacter
viral
famili
detect
protein
sequenc
similar
known
viral
famili
genbank
would
go
unidentifi
possibl
approach
identifi
highli
diverg
virus
includ
analysi
taxonom
unclassifi
contig
often
found
viral
metagenom
studi
extens
contig
target
pcr
metagenom
sequenc
may
allow
detect
distant
homolog
known
viru
presenc
unclassifi
sequenc
differ
patient
might
also
support
claim
detect
new
viral
famili
would
ultim
requir
direct
evid
viral
replic
amplif
vitro
vivo
seroconvers
expos
host
singl
genom
new
viral
famili
character
constitu
genera
speci
readili
detect
use
sequenc
similar
search
character
novel
viral
famili
particular
host
group
vertebr
arthropod
protist
plant
prokaryot
therefor
facilit
detect
viral
homologu
host
signific
fraction
common
human
diseas
includ
acut
gastroenter
acut
respiratori
tract
infect
hepat
enceph
remain
without
infecti
etiolog
autoimmun
diseas
cancer
may
also
induc
still
unidentifi
viral
trigger
viral
metagenom
therefor
provid
simpl
tool
identifi
candid
pathogen
diseas
clinic
diagnost
laboratori
frequent
use
cell
cultur
occas
observ
viral
cytopath
effect
induc
unidentifi
virus
viral
concentr
high
random
amplif
even
superfici
dna
sequenc
ie
plasmid
subclon
rapidli
character
viral
genom
cell
cultur
supernat
sinc
recent
deploy
viral
metagenom
quickli
led
genet
character
numer
human
anim
virus
mani
new
virus
discov
clinic
sampl
patient
unexplain
symptom
identif
context
may
coincident
may
simpli
reflect
harmless
common
infect
evid
pathogen
orphan
virus
therefor
requir
virus
may
includ
diagnost
test
diagnosi
infect
particular
viral
pathogen
treatment
exist
may
prevent
unnecessari
intervent
antibiot
treatment
improv
palli
measur
transmiss
prevent
data
requir
infecti
agent
gener
accept
pathogen
previous
review
depth
human
inocul
orphan
virus
preclud
indirect
evid
pathogen
reli
larg
observ
natur
infect
initi
question
often
whether
newli
character
viru
actual
human
viru
simpli
ingest
inhal
pass
without
consequ
gut
bronchi
lumen
common
detect
ingest
plant
anim
insect
viral
nucleic
acid
human
anim
stool
attest
capac
surviv
digest
track
detect
viru
specif
human
antibodi
use
show
replic
human
host
viru
detect
blood
tissu
csf
oppos
gut
respiratori
secret
skin
may
also
consid
evid
human
replic
sinc
difficult
conceiv
larg
number
viral
particl
could
passiv
transfer
intern
anatom
compart
viral
replic
human
cell
cultur
may
also
reflect
human
tropism
host
restrict
bypass
cell
cultur
mani
virus
grow
nonhost
speci
cell
line
vitro
replic
consid
definit
evid
determin
whether
human
viru
pathogen
often
start
compar
preval
match
diseas
case
healthi
control
use
pcr
singl
nest
pcr
quantit
pcr
assay
rapidli
design
sensit
detect
viral
load
measur
major
block
perform
casecontrol
studi
acquir
larg
number
sampl
unexplain
diseas
case
healthi
control
sampl
typic
collect
medic
care
facil
altern
control
sampl
may
collect
patient
unrel
symptom
viral
exposur
suscept
vari
greatli
differ
human
popul
case
control
need
care
match
epidemiolog
especi
age
geograph
proven
possibl
gener
exposur
virus
sociodemograph
occup
failur
properli
match
case
control
may
lead
mislead
result
compar
group
differ
level
harmless
commens
viru
infect
diseas
associ
studi
would
optim
also
perform
differ
age
group
differ
contin
result
associ
studi
strongli
suggest
pathogen
role
sampl
cluster
diseas
outbreak
may
also
use
test
diseas
associ
viru
present
patient
within
outbreak
rare
unaffect
local
control
may
consid
associ
symptom
especi
potenti
infecti
culprit
shown
absent
singl
diseas
case
may
also
highli
inform
longitudin
sampl
collect
show
rise
declin
concentr
new
viru
coincid
onset
resolut
symptom
known
pathogen
detect
use
either
batteri
specif
test
viral
metagenom
seroconvers
convalesc
sera
also
often
use
time
infect
onset
symptom
infect
hcv
hiv
viral
replic
particl
releas
may
linger
long
period
even
establish
lifelong
chronic
infect
parvovirus
may
even
retain
vivo
like
inert
pcr
detect
form
year
demonstr
seroconvers
convalesc
sera
igm
igg
detect
recent
prior
antibodi
neg
bleed
temporarili
associ
infect
onset
symptom
neutral
viral
antigen
bind
antibodi
may
use
neutral
antibodi
test
requir
prior
viral
amplif
cultur
may
problemat
virus
antibodyantigen
bind
assay
requir
gener
properli
fold
modifi
viral
epitop
assay
calibr
typic
use
known
antibodi
posit
sera
reagent
may
readili
avail
absenc
posit
neg
control
sera
may
circumv
set
threshold
level
base
bimod
distribut
antibodi
reactiv
within
popul
base
inflect
point
rank
bind
assay
signal
detect
viral
replic
express
affect
tissu
liver
hepat
brain
csf
enceph
also
provid
support
evid
pathogen
role
strong
associ
recent
describ
merkel
cell
polyomaviru
mcv
merkel
cell
carcinoma
provid
exampl
convinc
diseas
associ
otherwis
highli
preval
infect
viru
found
clonal
integr
cell
tumor
viral
mutat
truncat
helicas
gene
presum
promot
transform
cell
surviv
prevent
viral
replic
complic
diseas
associ
studi
extent
viral
genet
divers
shown
recent
character
viral
group
exampl
high
number
serotypegenotyp
found
within
human
enteroviru
speci
associ
varieti
symptom
http
wwwpicornaviridaecomenterovirusprototypeshevbprototypeshtm
group
similarli
genet
diverg
virus
may
therefor
equal
divers
phenotyp
determin
pathogen
new
viral
group
serotypegenotyp
therefor
consid
separ
increas
number
sampl
requir
detect
suffici
number
infect
measur
possibl
diseas
associ
mani
virus
common
caus
symptom
small
subset
infect
detect
diseas
associ
viru
frequent
detect
healthi
control
must
found
still
higher
fraction
unexplain
match
diseas
case
viru
respons
small
fraction
unexplain
case
may
difficult
increas
preval
rise
high
background
asymptomat
infect
two
group
common
human
virus
found
plasma
anelloviru
genu
gbvc
flavivirida
famili
initi
detect
hepat
patient
first
thought
associ
condit
studi
show
anellovirus
extrem
divers
nearli
univers
human
plasma
like
transmit
close
famili
contact
earli
birth
gbvc
also
shown
common
infect
especi
individu
expos
blood
product
associ
either
group
viru
hepat
confirm
given
anellovirus
exhibit
extrem
degre
genet
variabl
remain
possibl
subset
associ
diseas
situat
analog
papillomavirus
ubiquit
detect
make
associ
studi
challeng
coinfect
may
also
aggrav
symptom
diseas
induct
greatli
increas
context
infect
total
number
infect
particular
combin
virus
may
associ
symptom
deciph
complex
interact
requir
metagenom
microarray
technolog
queri
viru
famili
rather
singl
viru
assay
order
identifi
particip
virus
ultim
convincingli
demonstr
diseas
associ
requir
confirm
differ
research
group
use
differ
set
patient
control
sampl
reduct
symptom
diseas
preval
seen
use
specif
antivir
vaccin
direct
way
demonstr
human
viru
pathogen
sinc
measur
develop
highli
pathogen
preval
viral
infect
ultim
confirm
pathogen
first
depend
diseas
associ
test
describ
anim
virus
direct
inocul
host
speci
greatli
facilit
determin
pathogen
use
viral
metagenom
diagnost
purpos
appear
promis
signific
roadblock
remov
meanwhil
deep
sequenc
use
detect
viral
contamin
develop
manufactur
biolog
product
current
barrier
routin
use
viral
metagenom
diagnost
tool
includ
current
complex
slow
speed
difficult
data
interpret
access
streamlin
altern
method
qpcr
microarray
random
amplif
dna
librari
construct
protocol
current
complex
like
becom
simplifi
faster
near
futur
sequenc
time
also
like
reduc
shrink
time
clinic
sampl
collect
sequenc
data
gener
bioinformat
analysi
medic
use
hour
day
enhanc
appeal
sequenc
approach
diagnost
purpos
issu
sensit
allow
detect
copi
viral
genom
also
compar
use
spike
sampl
highli
sensit
pcr
base
microarray
method
cost
like
remain
major
barrier
especi
compar
singl
qpcr
assay
case
test
singl
viru
indic
limit
includ
access
appropri
comput
power
need
analyz
larg
sequenc
data
set
level
sequenc
diverg
refer
viral
genom
ie
blast
e
score
toler
mani
match
differ
region
genom
requir
confirm
presenc
viru
remain
determin
persist
problem
dna
contamin
medic
signific
low
level
viral
nucleic
acid
detect
also
need
resolv
issu
describ
success
address
deep
sequenc
potenti
replac
mani
virusspecif
test
singl
procedur
immedi
futur
microbi
sequenc
microarray
like
simpler
cheaper
rapid
tool
rapidli
screen
clinic
sampl
unbias
way
rapidli
grow
number
alreadi
genet
character
virus
interim
deep
sequenc
like
popular
research
use
viral
discoveri
resequenc
test
biolog
product
earli
develop
metagenom
identifi
mani
virus
unknown
pathogen
diseas
associ
requir
epidemiolog
wellmatch
case
healthi
control
group
viral
genet
divers
coinfect
complic
diseas
associ
studi
metagenom
rapid
diagnosi
infecti
agent
prematur
promis
